Blood Matters: For the 17th Year, Thousands of Hematologists Meet in Amsterdam ... 
MarketWatch (press release)
Dr Topp - Acute Lymphocytic Leukemia: impressive results with a bispecific antibody in patients with refractory disease. Dr Ramsy - How malignant cells in patients with Chronic Lymphocytic Leukemia escape the deadly T-cell attack.

and more » 

Amgen's BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete ... 
MarketWatch (press release)
... a Phase 2 study that showed treatment with blinatumomab (AMG 103) helped achieve a high-rate of complete response (CR) in 72 percent of adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL) treated in the study.
Amgen: AMG 103 Phase 2 Data Shows High CR Rate In Leukemia Patients NASDAQ

all 40 news articles » 

/C O R R E C T I O N -- Amgen/ 
MarketWatch (press release)
THOUSAND OAKS, Calif., May 16, 2012 /PRNewswire via COMTEX/ -- In the news release, Amgen's BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, ...
Amgen Presents Oncology Data Zacks.com

all 11 news articles » 

Chronic Lymphocytic Leukemia Drug Treatment Shows Promise 
LiveScience.com
An experimental drug, called ibrutinib, shows promise treating elderly patients with chronic lymphocytic leukemia, according to preliminary findings from a phase I/II clinical trial. Clinical trial results do not always hold up in later studies.
Kinder Drugs for Seniors dailyRx

all 5 news articles » 

72% complete response in Ph II leukemia study of Amgen's blinatumomab 
The Pharma Letter
... from a Phase II study that showed treatment with blinatumomab (AMG 103) helped achieve a high-rate of complete response (CR) in 72% of adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL) treated in the study.
Biomarker analysis revives fortunes of Amgen's rilotumumab PMLiVE

all 2 news articles » 

STAT3 Mutations Linked to Rare Leukemia 
MedPage Today
The patients with these mutations were more likely to have neutropenia and rheumatoid arthritis than other large granular lymphocytic leukemia patients without STAT3 gene mutations. Mutations in the STAT3 gene are common in patients with large granular ...
STAT3 Mutations ID'd in Rare Lymphoproliferative Disorder Doctors Lounge

all 4 news articles » 

EAC graduate battles cancer: Student, mother focuses on dream 
Eastern Arizona Courier
Marisa Borjon, 23, tackled books, tuition and all the challenges that come in obtaining a degree while battling acute lymphoblastic leukemia. She graduated from the Eastern Arizona College on May 11. Marisa Borjon became an adult, a single parent and a ...

 

Relay for Life continues to grow in the Falls 
Niagara Gazette
She's a survivor of acute lymphoblastic leukemia, typically a killer cancer of the white blood cells. But she stood on stage with her mother, Ashley Tolfa, and recited to everyone gathered the various hardships she's had to endure during her more than ...
Former Madison Resident with Leukemia to Benefit from Relay for Life Team TheAlternativePress.com (press release) (blog)

all 301 news articles » 

Adaptive Biotech Targets Year End for CLIA Certification, Assay to Detect ... 
GenomeWeb
The Seattle-based company, which changed its name from Adaptive TCR at the beginning of the year, is developing a sequencing-based assay to detect minimal residual disease in T-lineage acute lymphoblastic leukemia to help physicians predict a patient's ...

 

Wonderful benefit today 
The Sunday Dispatch
Faith was diagnosed back in the summer of 2011 with Acute lymphocytic. Commonly called acute childhood leukemia, it is cancer of the blood and bone marrow. Faith's chemotherapy treatments are being increased every week. This diagnosis has really turned ...